Cheaper Medicines for the Better Off? A Comparison of Medicine Prices and Client Socioeconomic Status Between Chain and Independent Retail Pharmacies in Urban India

Document Type : Original Article

Authors

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK

Abstract

Background
The growth of chain pharmacies in India, and other low- and middle-income countries (LMICs), is challenging the status quo of pharmacy retail markets which have historically been dominated by independent pharmacies. This raises the question of whether such organisations will have a positive impact on affordability and access to medicines.
 
Methods
This paper draws on a standardised patient (SP) survey to measure the prices of medicines and expenditure on consultations for two tracer conditions (suspected tuberculosis [TB] in an adult and diarrhoea in an absent child) at a random sample of 230 chain and independent pharmacies in Bengaluru. Asset data were collected from 808 exit interviews with pharmacy customers to determine socioeconomic profiles of clients.
 
Results
Chain pharmacies were found to provide lower priced medicines for patients seeking care for diarrhoea and TB, with expenditure also lower for diarrhoea patients, compared to independent pharmacies. This was seemingly driven by lower prices rather than number of medicines dispensed or prescribing habits. Despite the availability of cheaper medicines, chains served wealthier clients, compared to independent pharmacies.
 
Conclusion
The findings indicate the potential for chains to contribute to improving medicine affordability as they expand. However, any attempt to leverage this organisational model for public health good would need to take account of the current client-mix of these pharmacies and be accompanied by appropriate regulatory constraints in order to realise the potential benefits for poorer groups.

Keywords


  1. Smith F. The quality of private pharmacy services in low and middle-income countries: a systematic review. Pharm World Sci. 2009;31(3):351-361. doi:10.1007/s11096-009-9294-z
  2. Lowe RF, Montagu D. Legislation, regulation, and consolidation in the retail pharmacy sector in low-income countries. South Med Rev. 2009;2(2):35-44.
  3. IMS Consulting Group. Assessing the Growth of Pharmacy Chains. New York: IMS Consulting Group; 2014.
  4. Miller R, Goodman C. Performance of retail pharmacies in low- and middle-income Asian settings: a systematic review. Health Policy Plan. 2016;31(7):940-953. doi:10.1093/heapol/czw007
  5. Wafula FN, Miriti EM, Goodman CA. Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature. BMC Health Serv Res. 2012;12:223. doi:10.1186/1472-6963-12-223
  6. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240-249. doi:10.1016/s0140-6736(08)61762-6
  7. Bennett D, Yin W. The market for high-quality medicine: retail chain entry and drug quality in India. Rev Econ Stat. 2019;101(1):76-90.
  8. Bennett D, Yin W. The Market for High-Quality Medicine. Cambridge, MA: National Bureau of Economic Research (NBER); 2014.
  9. Scott P, Walker JT. Retailing under resale price maintenance: economies of scale and scope, and firm strategic response, in the inter-war British retail pharmacy sector. Bus Hist. 2018;60(6):807-832. doi:10.1080/00076791.2017.1340455
  10. Luo J, Kulldorff M, Sarpatwari A, Pawar A, Kesselheim AS. Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study. Ann Intern Med. 2019;171(9):605-611. doi:10.7326/m18-1138
  11. Singleton JA, Nissen LM. Future-proofing the pharmacy profession in a hypercompetitive market. Res Social Adm Pharm. 2014;10(2):459-468. doi:10.1016/j.sapharm.2013.05.010
  12. Frant H. High-powered and low-powered incentives in the public sector. J Public Adm Res Theory. 1996;6(3):365-381.
  13. Miller R, Hutchinson E, Goodman C. 'A smile is most important.' Why chains are not currently the answer to quality concerns in the Indian retail pharmacy sector. Soc Sci Med. 2018;212:9-16. doi:10.1016/j.socscimed.2018.07.001
  14. Government of Karnataka. Karnataka Slum Development Board. http://www.karnataka.gov.in/ksdb/Pages/Slum-Statistics.aspx.  Accessed February 8, 2018. Published 2016.
  15. National Sample Survey Organization (NSSO). National Sample Survey 2011-2012 (68th round). New Delhi, India: NSSO; 2011.
  16. Bhojani U, Thriveni B, Devadasan R, et al. Out-of-pocket healthcare payments on chronic conditions impoverish urban poor in Bangalore, India. BMC Public Health. 2012;12:990. doi:10.1186/1471-2458-12-990
  17. Mackintosh M, Channon A, Karan A, Selvaraj S, Cavagnero E, Zhao H. What is the private sector? understanding private provision in the health systems of low-income and middle-income countries. Lancet. 2016;388(10044):596-605. doi:10.1016/s0140-6736(16)00342-1
  18. Miller R, Goodman C. Do chain pharmacies perform better than independent pharmacies? evidence from a standardised patient study of the management of childhood diarrhoea and suspected tuberculosis in urban India. BMJ Glob Health. 2017;2(3):e000457. doi:10.1136/bmjgh-2017-000457
  19. National Pharmaceutical Pricing Authority. National Pharmaceutical Pricing Authority website. http://www.nppaindia.nic.in/.  Accessed November 30, 2017.
  20. King JJC, Das J, Kwan A, et al. How to do (or not to do) … using the standardized patient method to measure clinical quality of care in LMIC health facilities. Health Policy Plan. 2019;34(8):625-634. doi:10.1093/heapol/czz078
  21. Björnsdottir I, Granas AG, Bradley A, Norris P. A systematic review of the use of simulated patient methodology in pharmacy practice research from 2006 to 2016. Int J Pharm Pract. 2020;28(1):13-25. doi:10.1111/ijpp.12570
  22. Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21(6):459-468. doi:10.1093/heapol/czl029
  23. Bassani DG, Corsi DJ, Gaffey MF, Barros AJ. Local distributions of wealth to describe health inequalities in India: a new approach for analyzing nationally representative household survey data, 1992-2008. PLoS One. 2014;9(10):e110694. doi:10.1371/journal.pone.0110694
  24. Chakraborty NM, Fry K, Behl R, Longfield K. Simplified asset indices to measure wealth and equity in health programs: a reliability and validity analysis using survey data from 16 countries. Glob Health Sci Pract. 2016;4(1):141-154. doi:10.9745/ghsp-d-15-00384
  25. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data--or tears: an application to educational enrollments in states of India. Demography. 2001;38(1):115-132. doi:10.1353/dem.2001.0003
  26. Basker E. Selling a cheaper mousetrap: Wal-Mart's effect on retail prices. J Urban Econ. 2005;58(2):203-229. doi:10.1016/j.jue.2005.03.005
  27. Jia P. What happens when Wal-Mart comes to town: an empirical analysis of the discount retailing industry. Econometrica. 2008;76(6):1263-1316.
  28. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Flexibility in community pharmacy: a qualitative study of business models and cognitive services. Pharm World Sci. 2010;32(2):130-138. doi:10.1007/s11096-009-9355-3
  29. Reardon T, Timmer CP, Minten B. Supermarket revolution in Asia and emerging development strategies to include small farmers. Proc Natl Acad Sci U S A. 2012;109(31):12332-12337. doi:10.1073/pnas.1003160108
  30. Bloom G, Standing H, Lucas H, Bhuiya A, Oladepo O, Peters DH. Making health markets work better for poor people: the case of informal providers. Health Policy Plan. 2011;26(Suppl 1):i45-52. doi:10.1093/heapol/czr025
  31. Gautham M, Shyamprasad KM, Singh R, Zachariah A, Singh R, Bloom G. Informal rural healthcare providers in North and South India. Health Policy Plan. 2014;29(Suppl 1):i20-29. doi:10.1093/heapol/czt05
  32. George A, Iyer A. Unfree markets: socially embedded informal health providers in northern Karnataka, India. Soc Sci Med. 2013;96:297-304. doi:10.1016/j.socscimed.2013.01.022
  33. Xi X, Huang Y, Lu Q, Ung COL, Hu H. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China. Int J Clin Pharm. 2019;41(2):478-487. doi:10.1007/s11096-019-00802-w
  34. Athiyah U, Setiawan CD, Nugraheni G, Zairina E, Utami W, Hermansyah A. Assessment of pharmacists' knowledge, attitude and practice in chain community pharmacies towards their current function and performance in Indonesia. Pharm Pract (Granada). 2019;17(3):1518. doi:10.18549/PharmPract.2019.3.1518
  35. Sing WS. Pharmacy practice in Malaysia. Malays J Pharm Sci. 2001;1(1):3-9.
  36. Kumar S. Foreign direct investment in multi-brand retail: opportunities and threats. Indian J Mark. 2012;42(5):47-52.
  37. The Hindu. Centre Opens Arms to Single Brand Retail FDI. The Hindu; 2018.

Articles in Press, Corrected Proof
Available Online from 09 November 2020
  • Receive Date: 03 April 2020
  • Revise Date: 25 September 2020
  • Accept Date: 21 October 2020